Next Article in Journal
Spotlight on HIV-1 Nef: SERINC3 and SERINC5 Identified as Restriction Factors Antagonized by the Pathogenesis Factor
Next Article in Special Issue
Mouse Systems to Model Hepatitis C Virus Treatment and Associated Resistance
Previous Article in Journal
The Dual Role of Exosomes in Hepatitis A and C Virus Transmission and Viral Immune Activation
Previous Article in Special Issue
Virologic Tools for HCV Drug Resistance Testing
Article Menu

Export Article

Open AccessReview
Viruses 2015, 7(12), 6716-6729; doi:10.3390/v7122968

Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals

1,†
and
2,†,*
1
Plymouth University, Peninsula School of Medicine and Dentistry, Plymouth PL6 8BU, UK
2
Plymouth University, Peninsula School of Medicine and Dentistry, Plymouth PL6 8BU, UK
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Thomas Baumert
Received: 6 October 2015 / Revised: 24 November 2015 / Accepted: 8 December 2015 / Published: 18 December 2015
(This article belongs to the Special Issue HCV Drug Resistance)
View Full-Text   |   Download PDF [671 KB, uploaded 18 December 2015]   |  

Abstract

There has been a remarkable transformation in the treatment of chronic hepatitis C in recent years with the development of direct acting antiviral agents targeting virus encoded proteins important for viral replication including NS3/4A, NS5A and NS5B. These agents have shown high sustained viral response (SVR) rates of more than 90% in phase 2 and phase 3 clinical trials; however, this is slightly lower in real-life cohorts. Hepatitis C virus resistant variants are seen in most patients who do not achieve SVR due to selection and outgrowth of resistant hepatitis C virus variants within a given host. These resistance associated mutations depend on the class of direct-acting antiviral drugs used and also vary between hepatitis C virus genotypes and subtypes. The understanding of these mutations has a clear clinical implication in terms of choice and combination of drugs used. In this review, we describe mechanism of action of currently available drugs and summarize clinically relevant resistance data. View Full-Text
Keywords: resistance; hepatitis C; direct acting antivirals; breakthrough variants resistance; hepatitis C; direct acting antivirals; breakthrough variants
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ahmed, A.; Felmlee, D.J. Mechanisms of Hepatitis C Viral Resistance to Direct Acting Antivirals. Viruses 2015, 7, 6716-6729.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top